Understanding how amino acid availability affects T-cell function in tumors.
Identifying and Targeting Drivers of Impaired Translation in Tumor-infiltrating CD8+ T-cells.
This study is looking at how the availability of certain nutrients called amino acids affects the ability of important immune cells, called CD8+ T-cells, to fight cancer, with the goal of finding better ways to boost cancer treatments for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sloan-Kettering Inst Can Research NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11250187 on NIH RePORTER |
What this research studies
This research investigates the role of amino acid availability in the function of tumor-infiltrating CD8+ T-cells, which are crucial for anti-tumor immunity. The study aims to uncover how a lack of amino acids can lead to T-cell exhaustion, reducing their effectiveness in fighting cancer. By examining the mechanisms that limit T-cell function within the tumor microenvironment, the researchers hope to identify new strategies to enhance the efficacy of immune checkpoint blockade therapies. Patients may benefit from insights that could lead to improved cancer treatments targeting T-cell dysfunction.
Who could benefit from this research
Good fit: Ideal candidates for this research are cancer patients whose tumors are characterized by poor responses to immune checkpoint blockade therapies.
Not a fit: Patients with tumors that are already responsive to immune checkpoint blockade therapies may not receive additional benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer therapies that enhance T-cell responses in patients with tumors that currently do not respond to existing treatments.
How similar studies have performed: Other research has shown promise in understanding T-cell metabolism and its impact on cancer treatment, suggesting that this approach could lead to significant advancements.
Where this research is happening
New York, United States
- Sloan-Kettering Inst Can Research — New York, United States (Active)
Researchers
- Principal investigator: Chen, Yan-Ting — Sloan-Kettering Inst Can Research
- Study coordinator: Chen, Yan-Ting
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.